Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Davis, D. Eastman, H. McPhillips, M. Raebel, S. Andrade, David Smith, M. Yood, S. Dublin, R. Platt (2011)
Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta‐blockers during pregnancyPharmacoepidemiology and Drug Safety, 20
Erik Larsen, Per Damkier, Lars Pedersen, J. Fenger‐Grøn, R. Mikkelsen, R. Nielsen, V. Linde, H. Knudsen, L. Skaarup, Poul Videbech (2015)
Use of psychotropic drugs during pregnancy and breast‐feedingActa Psychiatrica Scandinavica, 132
A. Caton, E. Bell, C. Druschel, M. Werler, A. Lin, M. Browne, L. McNutt, P. Romitti, A. Mitchell, R. Olney, A. Correa (2009)
Antihypertensive Medication Use During Pregnancy and the Risk of Cardiovascular MalformationsHypertension, 54
Roland Lennestål, Petra Olausson, B. Källén (2009)
Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infantsEuropean Journal of Clinical Pharmacology, 65
L. Duan, Angie Ng, Wansu Chen, H. Spencer, J. Nguyen, A. Shen, Ming-Sum Lee (2017)
&bgr;-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac AnomaliesJAMA Internal Medicine, 177
Letters Corresponding Author: Laxmi V. Ghimire, MD, Gladstone Institute of Author Affiliations: Department of Pharmacology, Izmir Katip Celebi University Cardiovascular Disease (GICD), 1650 Owens St, San Francisco, CA 94158 School of Medicine, Izmir, Turkey (Keskin-Arslan, Akoz); Terafar-Izmir Katip (laxmivilasg@gmail.com; laxmi.ghimire@ucsf.edu). Celebi University Teratology Information, Training, and Research Center, Izmir, Turkey (Kaplan). Conflict of Interest Disclosures: None reported. Corresponding Author: Yusuf Cem Kaplan, MD, Department of Editorial Note: This letter was shown to the corresponding author of the Pharmacology, Izmir Katip Celebi University School of Medicine, Izmir Katip original article, who declined to reply on behalf of the authors. Celebi University Teratology Information, Training, and Research Center, Izmir 1. Mandalenakis Z, Rosengren A, Skoglund K, Lappas G, Eriksson P, Dellborg M. Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi, Klinik Survivorship in Children and Young Adults With Congenital Heart Disease in Farmakoloji ve Toksikoloji Birimi, 35360, Karabağlar, İzmir, Türkiye Sweden. JAMA Intern Med. 2017;177(2):224-230. doi:10.1001/jamainternmed (seawise@gmail.com). .2016.7765 Conflict of Interest Disclosures: None reported. 2. Hoffman JIE, ed. The Natural and Unnatural History of Congenital Heart Disease. 1. Duan L, Ng A, Chen W, et al. β-Blocker exposure in pregnancy and risk of fetal Oxford, England: Wiley-Blackwell; 2009. cardiac anomalies. JAMA
JAMA Internal Medicine – American Medical Association
Published: Nov 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.